BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Han RS, Hao JW, Wang T, Xin Z, Fan GX, Wang GD, Liu MM, Liu CX, Yang QZ, Yang ZW, Lv XY, Zhang C, Bian G, Meng J, Cui ZQ, Yun XJ, Cao JH, Li SH, Fan JF, Ma HG, Gao FY, Mao T, Tian ZB, Song XH, Yu YN. Efficacy and safety of triple therapy with vonoprazan for Helicobacter pylori eradication: A multicenter, prospective, randomized controlled trial. World J Gastroenterol 2025; 31(28): 109001 [PMID: 40741473 DOI: 10.3748/wjg.v31.i28.109001]
URL: https://www.wjgnet.com/1007-9327/full/v31/i28/109001.htm
Number Citing Articles
1
Vasily Isakov, Alexei Goncharov. Breaking barriers in the first-line <i>Helicobacter pylori</i> treatment: Chinese multicenter trial validates vonoprazan-based triple therapyWorld Journal of Gastroenterology 2025; 31(40): 112312 doi: 10.3748/wjg.v31.i40.112312